Shopping Cart
- Remove All
- Your shopping cart is currently empty
SARS-CoV-2 nsp13-IN-4 (C4 (d)) is a potent and selective small-molecule inhibitor of nsp13 helicase, inhibiting the ssDNA+ ATPase activity of nsp13 with an IC50 of 57 μM, and providing a broad-spectrum antiviral effect.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $1,520 | 6-8 weeks | |
50 mg | $1,980 | 6-8 weeks | |
100 mg | $2,500 | 6-8 weeks |
Description | SARS-CoV-2 nsp13-IN-4 (C4 (d)) is a potent and selective small-molecule inhibitor of nsp13 helicase, inhibiting the ssDNA+ ATPase activity of nsp13 with an IC50 of 57 μM, and providing a broad-spectrum antiviral effect. |
In vitro | SARS-CoV-2 nsp13-IN-4 (C4 (d)) inhibits the ssDNA+ ATPase and ssDNA ATPase activities of nsp13, with IC50 values of 57 μM and 240 μM, respectively [1]. |
Molecular Weight | 407.26 |
Formula | C20H15BrN4O |
Cas No. | 923140-39-0 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.